SC
CVS icon

Stralem & Co’s CVS Health CVS Stock Holding History

Stralem & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-268,170
Closed -$21.1M – 50
2017
Q1 		$21.1M Sell
268,170
-3,900
-1% -$311K 2.46% 26
2016
Q4 		$21.5M Sell
272,070
-1,530
-0.6% -$124K 2.56% 26
2016
Q3 		$24.3M Buy
273,600
+24,200
+10% +$2.28M 2.82% 24
2016
Q2 		$23.9M Sell
249,400
-21,050
-8% -$2.1M 2.76% 21
2016
Q1 		$28.1M Sell
270,450
-15,848
-6% -$1.54M 3.07% 11
2015
Q4 		$28M Sell
286,298
-97,800
-25% -$9.58M 2.83% 20
2015
Q3 		$37.1M Sell
384,098
-52,700
-12% -$5.54M 3.08% 13
2015
Q2 		$45.8M Sell
436,798
-98,952
-18% -$10.1M 3.14% 8
2015
Q1 		$55.3M Buy
+535,750
New +$54.2M 3.09% 11

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Stralem & Co's CVS Position: Q2 2017 in Review

Stralem & Co sold out of CVS Health (CVS) in Q2 2017, closing a stake of 268,170 shares — an estimated $21.1M sold.

Stralem & Co first reported a position in CVS in Q1 2015 and held it in 9 quarters. The position peaked at $55.3M in Q1 2015. 1,552 funds tracked by Wall St. Rank hold CVS as of Q2 2017.

  • Stralem & Co reported no remaining CVS Health position as of Q2 2017 after selling out during the quarter.
  • Stralem & Co sold 268,170 CVS Health shares in Q2 2017, an estimated $21.1M.
  • Stralem & Co first reported a position in CVS Health in Q1 2015 and held it in 9 quarters.
  • Stralem & Co's CVS Health position peaked at $55.3M in Q1 2015.
  • 1,552 funds tracked by Wall St. Rank held CVS Health as of Q2 2017.

Based on Stralem & Co's 13F filing for Q2 2017, filed 19 Jul 2017.